FINWIRES · TerminalLIVE
FINWIRES

$HCA

18 stories mentioning HCA

Every FINWIRES story that references HCA, newest first.

Sectors

Sector Update: Health Care Stocks Softer Late Afternoon

Health care stocks fell late Monday afternoon with the NYSE Health Care Index easing 0.2% and the State Street Health Care Select Sector SPDR ETF (XLV) losing 0.3%.The iShares Biotechnology ETF (IBB) shed 0.4%.In corporate news, Eli Lilly (LLY) agreed to acquire Ajax Therapeutics for up to $2.3 billion in cash. The deal includes an upfront payment and subsequent payouts based on the achievement of clinical and regulatory milestones. Lilly shares fell 1.6%.HCA Healthcare (HCA) may face pressure through at least H1 as investors rotate toward managed care, although better trends in March and in-line exchange dynamics support the longer-term outlook, RBC Capital Markets said. HCA Healthcare shares rose 3.2%.Organon (OGN) shares jumped 17% after the company agreed to be acquired by India's Sun Pharmaceutical Industries for $14 a share in cash, valuing the company at $11.75 billion.Moderna (MRNA) is facing a patent infringement lawsuit from CureVac, which alleged that Moderna's COVID-19 vaccine Spikevax used its proprietary mRNA technology without authorization, Reuters reported Saturday. Moderna shares fell 4.7%.

$HCA$LLY$MRNA$OGN
Sectors

Sector Update: Health Care

Health care stocks were lower late Monday afternoon with the NYSE Health Care Index easing 0.2% and the State Street Health Care Select Sector SPDR ETF (XLV) decreasing 0.3%.The iShares Biotechnology ETF (IBB) shed 0.5%.In corporate news, HCA Healthcare (HCA) may face near-term pressure through at least the first half as investors rotate toward managed care, although better trends in March and in-line exchange dynamics support the longer-term outlook, RBC Capital Markets said. RBC reiterated its outperform rating and lowered its price target to $534 from $593. HCA Healthcare shares were up 2.3%.

$HCA
Wire

HCA Healthcare Pressure Expected to Persist Through Q2 on Managed Care Rotation, RBC Says

HCA Healthcare (HCA) may face near-term pressure through at least the first half as investors rotate toward managed care, although better trends in March and in-line exchange dynamics support the longer-term outlook, RBC Capital Markets said.The company's weaker-than-expected Q1, driven by lower respiratory volume and weather-related disruption, has increased near-term concern around hospital volumes and patient mix.RBC said in a Sunday note that it expects Friday's share price decline to persist through Q2 as management works to demonstrate execution against growth targets and as investors await further clarity on the impact of ePTC expiry.The investment firm said March volumes improved meaningfully while exchange-related pressure remains manageable. HIX declines reflect both lost volume and patients in grace periods already incorporated into bad debt reserves. Surgical and outpatient trends remain broadly consistent with its full-year outlook, according to the note.RBC reiterated its outperform rating and lowered its price target to $534 from $593, citing increased caution on near-term hospital volume and mix dynamics and a broader rotation toward managed care.Price: $439.41, Change: $+6.95, Percent Change: +1.61%

$HCA
Wire

HCA Healthcare Unit Plans Senior Notes Offering

HCA Healthcare (HCA) unit HCA plans to offer senior notes, with terms such as maturity, interest rate and size to be set at pricing.Net proceeds will be for general corporate purposes, which may include repaying borrowings under a $4 billion commercial paper program and potentially redeeming portions of notes due in 2026, the company said Monday in a statement.Price: $443.15, Change: $+10.69, Percent Change: +2.47%

$HCA
Research

Research Alert: CFRA Maintains Buy Rating On Shares Of Hca Healthcare

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month price target to $515 from $565, reflecting a 2026 P/E of 17x, a premium to hospital operator peers given our view of HCA's stronger margin profile historically and attractive near-term earnings growth trajectory, and above HCA's three-year historical forward average of 15.3x. We lower our 2026 EPS estimate by $0.03 to $30.30 and raise our 2027 estimate by $0.04 to $33.31. HCA estimates a $150M EBITDA headwind during Q1, relative to Q1 2025, from the expiration of the ACA enhanced premium tax credits at year-end 2025, which contributed to significant coverage losses and put upward pressure on uncompensated care. However, the company maintained the full-year outlook for a $600M-$900M impact, which we view favorably, though we think the ACA coverage landscape could be volatile in the coming quarters.

$HCA
Equities

S&P 500 Posts Fourth Consecutive Weekly Gain, Hits New Highs

The Standard & Poor's 500 index rose 0.55% this week to another round of fresh highs, led by the energy and technology sectors as oil prices climbed and Intel's (INTC) earnings topped views.The S&P 500 ended Friday's session at 7,165.08, its highest closing level yet. The market benchmark also reached a fresh intraday high on Friday at 7,168.59.This marks the S&P 500's fourth weekly gain in a row. It's up 9.8% for April and 4.7% for the year.US retail sales last month logged the largest rise since March 2025, data released earlier this week showed. The increase, however, came amid a surge in spending at gasoline station as the Middle East conflict led to higher prices.US consumer sentiment improved from an initial April estimate, and consumer sentiment remained at a record low as near-term inflation expectations logged the biggest monthly increase in a year, according to final University of Michigan survey results.The energy sector led the week's advance, rising 3.2%, followed by a 3.1% increase in technology and a 1.2% rise in consumer staples. Utilities and materials also edged higher.The energy sector's increase came as crude oil futures rose amid continued uncertainty in the Middle East.Baker Hughes (BKR) had the largest percentage gain in the energy sector, climbing 15% as the company reported Q1 adjusted earnings and revenue above analysts' mean estimates.The technology sector was boosted by stronger-than expected first-quarter results from Intel amid artificial intelligence-driven demand. The chip maker also issued an upbeat Q2 outlook. Its shares jumped 21% on the week.On the downside, health care fell 3.1%, followed by a 1.9% drop in financials and a 1.5% slip in real estate. Communication services, industrials and consumer discretionary also edged lower.HCA Healthcare (HCA) led the decliners in health care, falling 11%. The hospital operator's first-quarter results exceeded market expectations but the company also said it didn't experience its typical increase in seasonal volume during the quarter, mainly due to a drop in admissions related to respiratory issues.Thermo Fisher Scientific (TMO) also lost 11%. The medical device manufacturer raised its full-year outlook as first-quarter results came in stronger than expected, but investors were disappointed by its organic growth, which fell short of analysts' estimates.Next week's earnings calendar features a number of large companies including Google parent Alphabet (GOOG), Microsoft (MSFT), Amazon.com (AMZN), Facebook parent Meta Platforms (META), Apple (AAPL), Eli Lilly (LLY), Mastercard (MA), Caterpillar (CAT), Merck (MRK), Berkshire Hathaway (BRK.A, BRK.B), Verizon Communications (VZ), Visa (V) and Coca-Cola (KO).Economic data will include Q1 gross domestic product, March personal consumption expenditures and April consumer confidence, among other reports.The Federal Reserve's Federal Open Market Committee will hold a two-day rate policy meeting, concluding on Wednesday.

Dow JonesNasdaq CompositeS&P 500$BKR$HCA$INTC$TMO
Sectors

Sector Update: Health Care Stocks Fall Late Afternoon

Health care stocks were lower late Friday afternoon, with the NYSE Health Care Index down 1.1% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 1.4%.The iShares Biotechnology ETF (IBB) fell 1%.In sector news, the US Food and Drug Administration said it was launching regulatory actions to back the development of psychedelic therapies to treat mental illness. The move builds on President Donald Trump's recent executive order directing the Department of Health and Human Services to accelerate access to treatments for people with serious mental illness, the FDA said.In corporate news, HCA Healthcare's (HCA) Q1 results exceeded market expectations, but the hospital operator said it did not see its usual seasonal lift in admissions amid declines in respiratory activity. Its shares dropped 9%.Organon (OGN) shares surged 32% amid a report that India's Sun Pharmaceutical Industries was planning a $13 billion bid for the company.Compass Pathways (CMPS) shares rose 4.8% after it said Friday the US Food and Drug Administration has granted its rolling review request for its new drug application and selected COMP360 for the Commissioner's National Priority Voucher program for treatment-resistant depression.Sanofi (SNY) priced a 2.3 billion euro ($2.7 billion) offering of notes under its Euro Medium Term Note program. Its shares were down 1.5%.

$CMPS$HCA$OGN$SNY
Sectors

Sector Update: Health Care Stocks Decline in Afternoon Trading

Health care stocks were lower Friday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each shedding 1.4%.The iShares Biotechnology ETF (IBB) decreased 0.7%.In sector news, the US Food and Drug Administration said it was launching regulatory actions to back the development of psychedelic therapies to treat mental illness. The move builds on President Donald Trump's recent executive order directing the Department of Health and Human Services to accelerate access to treatments for people with serious mental illness, the FDA said.In corporate news, HCA Healthcare's (HCA) Q1 results exceeded market expectations, but the hospital operator said it did not see its usual seasonal lift in admissions amid declines in respiratory activity. Its shares dropped 9%.Organon (OGN) shares surged 28% amid a report that India's Sun Pharmaceutical Industries was planning a $13 billion bid for the company.Compass Pathways (CMPS) shares rose 5% after it said Friday the US Food and Drug Administration has granted its rolling review request for its new drug application and selected COMP360 for the Commissioner's National Priority Voucher program for treatment-resistant depression.

$CMPS$HCA$OGN
Wire

Top Midday Decliners

Charter Communications (CHTR) reported Q1 earnings on Friday below the FactSet consensus and revenue which declined from a year ago.Shares sank 22% following an increase in intraday trading volume to over 8.1 million from a daily average of about 1.95 million.HCA Healthcare's (HCA) Q1 results exceeded market expectations, but the hospital operator said it did not see its usual seasonal lift in admissions amid declines in respiratory activity.Shares dropped 9%, with intraday trading volume at over 2.28 million, versus a daily average of roughly 1.1 million.Price: $186.25, Change: $-55.53, Percent Change: -22.97%

$CHTR$HCA
Sectors

Sector Update: Health Care

Health care stocks declined Friday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each shedding 1.4%.The iShares Biotechnology ETF (IBB) decreased 0.8%.In corporate news, HCA Healthcare's (HCA) Q1 results exceeded market expectations, but the hospital operator said it did not see its usual seasonal lift in admissions amid declines in respiratory activity. Its shares dropped 8.7%.

$HCA
Wire

Top Midday Stories: Intel Shares Soar After Q1 Beat; Meta to use AWS Graviton Cores

The S&P 500 and Nasdaq Composite were up, while the Dow Jones Industrial Average was down in late-morning trading Friday, as investors are hopeful that peace talks will soon take place between the US and Iran.In company news, Intel (INTC) reported fiscal Q1 adjusted earnings late Thursday of $0.29 per diluted share, up from $0.13 a year earlier and above the FactSet consensus of $0.02. Fiscal Q1 revenue was $13.58 billion, up from $12.67 billion a year ago and above the FactSet consensus of $12.42 billion. For fiscal Q1, the company said it expects adjusted EPS of $0.20 and revenue of $13.8 billion to $14.8 billion, above the FactSet consensus of $0.10 and $13.1 billion, respectively. Intel shares were up 23.7% around midday.Meta Platforms (META) said Friday it entered into an agreement to incorporate tens of millions of Amazon (AMZN) Web Services Graviton cores into its computing network. The company said it requires increased central processing capabilities to support the development of agentic AI systems capable of reasoning and executing complex tasks. Meta shares were up 1.4%, while Amazon shares were up 2.5%.Procter & Gamble (PG) reported fiscal Q3 core earnings per diluted share Friday of $1.59, up from $1.54 a year earlier and above the FactSet consensus of $1.56. Fiscal Q3 net sales were $21.24 billion, up from $19.78 billion a year ago and above the FactSet consensus of $20.53 billion. Procter & Gamble shares were up 3.8%.HCA Healthcare (HCA) reported Q1 adjusted earnings Friday of $7.15 per diluted share, up from $6.45 a year ago and above the FactSet consensus of $7.12. First-quarter revenue was $19.11 billion, up from $18.32 billion a year ago and above the FactSet consensus of $19.09 billion. HCA shares were down 8.0%.Charter Communications (CHTR) reported Q1 earnings Friday of $9.17 per diluted share, up from $8.42 a year earlier but below the FactSet consensus of $9.96. First-quarter revenue was $13.60 billion, down from $13.74 billion a year ago and above the FactSet consensus of $13.55 billion. Charter shares were down 22%.Price: $82.55, Change: $+15.77, Percent Change: +23.61%

$AMZN$CHTR$HCA$INTC$META$PG
US Markets

HCA Healthcare Tops First-Quarter Estimates; Respiratory Admissions Fall

HCA Healthcare's (HCA) first-quarter results exceeded market expectations, though the hospital operator said it did not see its usual seasonal lift in admissions amid declines in respiratory activity.The company on Friday reported adjusted earnings of $7.15 a share for the quarter ended March 31, up from $6.45 the year before, surpassing the FactSet-polled consensus of $7.12. Revenue improved 4.3% to $19.11 billion, topping the Street's view for $19.09 billion.HCA Healthcare didn't experience its typical increase in seasonal volume during the quarter, mainly due to respiratory activity, the company said. Admissions related to respiratory issues dropped 42% on a yearly basis, while respiratory-related emergency room visits slipped 32%. The winter storm in January also weighed on quarterly volume in certain markets, it said.The unfavorable volume headwinds were mostly offset by recognition of certain Medicaid supplemental programs, which weren't reflected in its initial full-year outlook, according to the company.HCA Healthcare's stock fell 7.4% in Friday trade, extending its year-to-date loss to 7.6%."The start of the year presented a dynamic environment for HCA Healthcare," Chief Executive Sam Hazen said in a statement.Same facility admissions edged up 0.9%, while emergency room visits nudged 0.3% higher, the company said. Same facility inpatient surgeries slipped 0.3%, while outpatient surgeries declined 1.7%.The firm continues to project net income to come in between $29.10 and $31.50 a share on a revenue range of $76.5 billion to $80 billion for 2026. The Street is looking for EPS of $30.39 and sales of $78.6 billion for the year.Price: $448.41, Change: $-25.62, Percent Change: -5.40%

$HCA
Sectors

Sector Update: Health Care Stocks Mixed Premarket Friday

Health care stocks were mixed premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.7% and the iShares Biotechnology ETF (IBB) 0.5% higher.HCA Healthcare (HCA) stock was down 9% even after the company reported higher Q1 adjusted earnings and revenue.Organon (OGN) shares were up more than 29% amid a report that India's Sun Pharmaceutical Industries was planning a $13 billion bid for the company.Senseonics (SENS) stock was up 1.6% after the company said it has launched the Eversense 365 continuous glucose monitoring system in Europe.

$HCA$IBB$OGN$SENS$XLV
Sectors

Sector Update: Health Care

Health care stocks were mixed premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.8% and the iShares Biotechnology ETF (IBB) 0.5% higher.HCA Healthcare (HCA) stock was down almost 9% even after the company reported higher Q1 adjusted earnings and revenue.

$HCA
Asia Markets

Israel-Lebanon Ceasefire Extension Nudges US Equity Futures Higher Pre-Bell

US equity futures nudged higher pre-bell Friday as Israel and Lebanon extended their ceasefire by three weeks in a meeting at the White House facilitated by President Donald Trump.Dow Jones Industrial Average futures were 0.1% lower, S&P 500 futures were up 0.4%, and Nasdaq futures were 1.3% lower.Fighting between Israel and Iran-backed militant group Hezbollah in Lebanon has been a key discussion point in negotiations to end the conflict in the Middle East. The Strait of Hormuz remains effectively closed to vessels, while the US maintains its blockade on Iranian ports.Trump said he was not in a hurry to reach a peace agreement with Iran, saying he wanted to make it "everlasting." He had extended the US-Iran ceasefire, calling the Iranian government "fractured," but Iran's Supreme Leader Ayatollah Mojtaba Khamenei on Thursday denied Trump's claim of disunity in the country's leadership.Traders tracked the latest round of earnings, with Procter & Gamble (PG) reporting higher fiscal Q3 financial results and HCA Healthcare (HCA) posting an increase in Q1 adjusted earnings and revenue.Oil prices were mostly flat, with front-month global benchmark North Sea Brent crude up 0.3% at $105.39 per barrel and US West Texas Intermediate crude 0.1% lower at $95.73 per barrel.The final University of Michigan consumer sentiment report for April, scheduled at 10 am ET, is expected to show consumer sentiment index coming in at 48.5, compared with the preliminary reading of 47.6, according to estimates compiled by Bloomberg.In other world markets, Japan's Nikkei closed 1% higher, Hong Kong's Hang Seng ended 0.2% higher, and China's Shanghai Composite finished 0.3% lower. Meanwhile, the UK's FTSE 100 was down 0.3%, and Germany's DAX index was 0.2% higher in Europe's early afternoon session.In equities, Intel (INTC) shares rose 26% after the company reported fiscal Q1 adjusted earnings and revenue, as well as issued fiscal Q2 guidance, that surpassed analyst estimates. Advanced Micro Devices (AMD) stock was 11% higher after DA Davidson upgraded the company's stock to buy from neutral and raised its price target to $375 from $220. Procter & Gamble shares were up 2.6% after the company's fiscal Q3 financial results beat analysts' consensus.On the losing side, HCA Healthcare shares dropped 7.8% after the company reported its Q1 financial results. Comcast (CMCSA) stock was down 2.7% after the company posted lower Q1 adjusted earnings from a year ago. Infosys (INFY) shares fell 2.6% despite reporting higher fiscal Q4 earnings and revenue.

Dow JonesNasdaq CompositeS&P 500$AMD$CMCSA$HCA$INFY$INTC$PG
Research

Research Alert: Hca: Share Repurchases Help Q1 Eps Meet Estimates Despite Volume Pressures

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:HCA Healthcare delivered Q1 2026 EPS of $7.15, in line with consensus and up 10.9% Y/Y, while revenue of $19.109B grew 4.3% and beat the $19.07B consensus estimate. Same-facility admissions rose 1.3%, though surgical volumes declined with inpatient and outpatient surgeries down 0.3% and 1.7%, respectively, reflecting softness in elective procedures and seasonal headwinds. Strong share repurchase activity of $1.571B during the quarter supported EPS growth despite volume pressures. Management reaffirmed 2026 guidance ranges, indicating confidence in navigating policy headwinds. Adjusted EBITDA margin compressed 50 bps to 19.9% due to challenging volumes and inflationary cost pressures, though operating cash flow surged 22% to $2.014B. We view the continued strong cash generation and $9.179B remaining share repurchase authorization as supportive of capital returns despite headwinds from ACA enhanced premium tax credit expirations and OBBBA Medicaid funding cuts.

$HCA
Japan

Israel-Lebanon Ceasefire Extension Nudges US Equity Futures Higher Pre-Bell

US equity futures were higher pre-bell Friday as Israel and Lebanon extended their ceasefire by three weeks in a meeting at the White House.Dow Jones Industrial Average futures were 0.1% higher, S&P 500 futures were up 0.5%, and Nasdaq futures were 1.4% lower.Fighting between Israel and Iran-backed militant group Hezbollah in Lebanon has been a key discussion point in negotiations to end the conflict in the Middle East. The Strait of Hormuz remains effectively closed to vessels, while the US maintains its blockade on Iranian ports.Trump said he was not in a hurry to reach a peace agreement with Iran, saying he wanted to make it "everlasting." He had extended the US-Iran ceasefire, calling the Iranian government "fractured," but Iran's Supreme Leader Ayatollah Mojtaba Khamenei on Thursday denied Trump's claim of disunity in the country's leadership.Traders tracked the latest round of earnings, with Procter & Gamble (PG) reporting higher fiscal Q3 financial results and HCA Healthcare (HCA) posting an increase in Q1 adjusted earnings and revenue.Oil prices were lower, with front-month global benchmark North Sea Brent crude down 0.5% at $104.57 per barrel and US West Texas Intermediate crude 1.2% lower at $94.66 per barrel.The final University of Michigan consumer sentiment report for April, scheduled at 10 am ET, is expected to show consumer sentiment index coming in at 48.5, compared with the preliminary reading of 47.6, according to estimates compiled by Bloomberg.

Dow JonesNasdaq CompositeS&P 500$HCA$PG
US Markets

Stocks Mostly Up Pre-Bell as Israel, Lebanon Agree to Extend Ceasefire

The benchmark US stock measures were mostly pointing higher before the open Friday as President Donald Trump announced an extension of the ceasefire between Israel and Lebanon.The S&P 500 edged up 0.1% and the Nasdaq increased 0.9%, while the Dow Jones Industrial Average declined 0.3%. The indexes finished the previous trading session lower.In a social media post on Thursday, Trump said the ceasefire between Israel and Lebanon will be extended by three weeks after representatives from the two countries met at the White House. Trump announced a 10-day ceasefire between Israel and Lebanon last week."The meeting went very well!" Trump wrote. "The United States is going to work with Lebanon in order to help it protect itself from Hezbollah."The conflict between Israel and Hezbollah in Lebanon has been a key sticking point in US-Iran peace efforts, which are showing no apparent signs of progress."Hopes for a resolution between the US and Iran are fading as peace talks stall," ING Bank said in a Thursday report. "If no progress is made, the market will become increasingly numb to the noise and headlines that have dictated price action recently."Trump on Thursday ordered the US navy to "shoot and kill any boat" placing mines in the Strait of Hormuz. Separately, the US leader claimed that the US has "total control" over the key oil supply chokepoint.Trump extended a ceasefire with Iran earlier in the week, though he said the naval blockade of Iranian ports would continue. Iran's Islamic Revolutionary Guard Corps on Wednesday reportedly seized two tankers attempting to cross the Strait of Hormuz.West Texas Intermediate crude oil rose 1.3% to $97.08 a barrel before the opening bell, while Brent gained 1.6% to $106.76.Treasury yields were trending upwards in premarket action, with the two-year rate increasing 1.5 basis points to 3.84% and the 10-year rate adding 0.8 basis points to 4.33%.Shares of Intel (INTC) jumped 27% pre-bell after the chipmaker reported first-quarter results above Wall Street's estimates. Advanced Micro Devices (AMD) climbed 11% while Lucid (LCID) rebounded 0.4% following a 9.3% drop at the close of Thursday.Procter & Gamble (PG), HCA Healthcare (HCA), SLB (SLB) and Charter Communications (CHTR) report their latest financial results before the bell, among others.Friday's economic calendar has the final University of Michigan consumer sentiment report for April at 10 am ET, followed by the weekly Baker Hughes oil-and-gas rig count at 1 pm.Gold declined 0.6% to $4,695 per troy ounce, while bitcoin was slightly up at $77,789.

Dow JonesNasdaq CompositeS&P 500$AMD$CHTR$HCA$INTC$LCID$PG$SLB